ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q1 2017. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,993,000 | +431.7% | 23,200 | +49.8% | 0.13% | +600.0% |
| Q2 2018 | $751,000 | +299.5% | 15,488 | +221.9% | 0.02% | +260.0% |
| Q1 2018 | $188,000 | -41.1% | 4,811 | -60.0% | 0.01% | -28.6% |
| Q1 2017 | $319,000 | +3.9% | 12,037 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $307,000 | -51.1% | 12,037 | -30.6% | 0.01% | -50.0% |
| Q3 2016 | $628,000 | +6.4% | 17,350 | 0.0% | 0.01% | +7.7% |
| Q2 2016 | $590,000 | – | 17,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |